Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06560762 · ClinicalTrials.gov registry record · Phase 1

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

A Phase 1 study of Heart Failure With Preserved Ejection Fraction (HFPEF), sponsored by Secretome Therapeutics.

Recruiting
Registry status
Phase 1
Development phase
12
Enrollment target
2
Study locations

NCT06560762 is a Phase 1 study of Heart Failure With Preserved Ejection Fraction (HFPEF) that is actively recruiting participants, run by Secretome Therapeutics. The registered enrollment target is 12 participants, below the 218-participant average among 9 other Heart Failure With Preserved Ejection Fraction (HFPEF) trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06560762, a Phase 1 study of Heart Failure With Preserved Ejection Fraction (HFPEF), is actively recruiting participants, sponsored by Secretome Therapeutics.

RECRUITING
Registry status
Phase 1
Development phase
12 participants
Enrollment target
2
Study locations

Study Summary

A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

Conditions Studied

Heart Failure With Preserved Ejection Fraction (HFPEF)

Interventions

  • DRUG STM01

Study Locations (2)

Illinois

  • Northwestern Medicine - Chicago

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2025-03-03
Est. Completion 2025-12-15
Phase Phase 1

Sponsor

Secretome Therapeutics

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06560762

The ClinicalTrials.gov registry entry for NCT06560762 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 9 other Heart Failure With Preserved Ejection Fraction (HFPEF) trials with a reported enrollment target (94% lower). The listed sponsor is Secretome Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction (HFPEF) appearing as the primary indexed condition, and to 1 intervention - of which STM01 is the first listed.

NCT06560762 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT06560762 about?

NCT06560762 is a clinical study titled "Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)". A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

What is the current status of trial NCT06560762?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2025-03-03. Estimated completion is 2025-12-15.

What conditions does trial NCT06560762 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction (HFPEF).

What interventions are being tested in trial NCT06560762?

The interventions under investigation include: STM01 (DRUG).

Who is sponsoring clinical trial NCT06560762?

This trial is sponsored by Secretome Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06560762 being conducted?

This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure With Preserved Ejection Fraction (HFPEF)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure With Preserved Ejection Fraction (HFPEF)

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.